PSMB1
MOLECULAR TARGETproteasome 20S subunit beta 1
PSMB1 (proteasome 20S subunit beta 1) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PSMB1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | mg 132 | 4.66 | 105 |
| 2 | carfilzomib | 3.69 | 39 |
| 3 | Bortezomib | 3.43 | 30 |
| 4 | epoxomycin | 3.30 | 26 |
| 5 | marizomib | 2.77 | 15 |
| 6 | ixazomib | 2.64 | 13 |
| 7 | delanzomib | 2.08 | 7 |
| 8 | Reserpine | 1.61 | 4 |
| 9 | Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as | 0.69 | 1 |
About PSMB1 as a Drug Target
PSMB1 (proteasome 20S subunit beta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented PSMB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PSMB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.